title: Are we on the path to solve the enigma of resistant hypertension: renal sympathetic denervation.
abstract: Renal sympathetic denervation (RSD) opens new perspectives and possibilities not only in the treatment of resistant hypertension but also of other cardiometabolic diseases. In patients with hypertension, it has been demonstrated that activity of the sympathetic nervous system correlates with grade of hypertension. Decreasing sympathetic activity using RSD significantly reduces blood pressure in resistant hypertension. It is too early to say a definite opinion about appropriateness of this method in the treatment of resistant hypertension, because there are not great studies with huge number of the patients. After we get and evaluate these results through a longer span of time, only than we shall know what is the role of RSD in the treatment of resistant hypertension and other cardiometabolic conditions related to increased function of the sympathetic nervous system, such as heart failure, diabetes mellitus, obstructive sleep apnea, renal disease with microalbuminuria and macroalbuminuria.
authors.affiliation: Clinic for Heart Disease, Clinical Center of University of Sarajevo, Sarajevo, Bosna and Herzegovina.
authors.forename: Vjekoslav
authors.initials: V
authors.lastname: Gerc
authors.affiliation: Clinic for Heart Disease, Clinical Center of University of Sarajevo, Sarajevo, Bosna and Herzegovina.
authors.forename: Marko
authors.initials: M
authors.lastname: Buksa
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use; D018660:Blood Pressure Monitoring, Ambulatory; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology / Q000601:surgery*; D012077:Renal Artery / Q000294:innervation*; D013562:Sympathectomy; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents
keywords: resistant hypertension; sympathetic denervation